Author

T. Radstake

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

S. Hiddingh· 2 shared A. Pandit· 1 shared E. D. Kaan· 1 shared F. M. A. Peters· 1 shared F. Verhagen· 1 shared J. H. de Boer· 1 shared J. J. W. Kuiper· 1 shared L. L. van den Hoogen· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

S. Hiddingh

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transcriptome network analysis implicates CX3CR1-positive type 3 dendritic cells in non-infectious uveitis

S. Hiddingh, A. Pandit, F. Verhagen, R. Rijken, N. Servaas, R. Komer-Wichers, N. t. Dam-van Loon, S. S. Imhof, T. Radstake, J. H. de Boer, J. J. W. Kuiper

The paper identifies CX3CR1-positive type 3 dendritic cells as implicated in non-infectious uveitis through transcriptome network analysis and flow cytometry.

bioRxiv · Nov 16, 2021Immunology

Inhibitory CD200-receptor signaling is rewired by type I interferon

M. van der Vlist, M. I. Pascoal Ramos, L. L. van den Hoogen, S. Hiddingh, L. Timmerman, T. A. P. de Hond, E. D. Kaan, M. van der Kroef, R. J. Lebbink, F. M. A. Peters, W. Khoury-Hanold, R. Fritsch-Stork, T. Radstake, L. Meyaard

This study shows that type I interferon alters CD200R signaling by promoting RasGAP cleavage, converting CD200R from an inhibitor to a potentiator of IFNG mRNA production in SLE patients.

bioRxiv · Feb 6, 2020Immunology